Paruch Kamil ( search by name in IS MU /auth )

Body na spoluautora Body za publikaci pro MU Odkaz ISVaV
0,00 0,00 Novel modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
0,00 0,00 2-Fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
0,00 0,00 Pyrazolotriazines as Kinase Inhibitors
0,00 0,00 Novel Pyrazolopyrimidines as Cyclin Dependent Kinase Inhibitors
0,00 0,00 Novel Pyrazolopyrimidines as Cyclin Dependent Kinase Inhibitors
0,00 0,00 Pyrazolopyrimidines as Cyclin Dependent Kinase Inhibitors
0,00 0,00 Novel Imidazopyrazines as Cyclin Dependent Kinase Inhibitors
0,00 0,00 Pyrazolopyrimidines as Protein Kinase Inhibitors
0,00 0,00 Novel pyrazolopyrimidines as novel cyælin dependent kinase inhibitors
0,00 0,00 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
0,00 0,00 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
32,43 32,43 Structure-guided discovery of cyclin-dependent kinase inhibitors
0,00 0,00 Synthesis of Substituted 3-Aminopyrazoles
0,00 0,00 Imidazopyrazines as protein kinase inhibitors
0,00 0,00 Imidazopyrazines as protein kinase inhibitors
0,00 0,00 Methods for inhibiting protein kinases
0,00 0,00 Methods for inhibiting protein kinases
0,00 0,00 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
0,00 0,00 Pyrazolopyrimidines as protein kinase inhibitors
0,00 0,00 Pyrazolopyrimidines as protein kinase inhibitors
0,00 0,00 Novel 4-cyano, 4-amino, and 4-aminomethyl Derivatives of Pyrazolo[1,5-a]pyridines, Pyrazolo[1,5-c]pyrimidines and 2-H-indazole Compounds and 5-cyano, 5-amino, and 5-aminomethyl Derivatives of Imidazo[1,2-a]pyridines, and Imidazo[1,5-a]pyrazines Compounds
0,00 0,00 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
37,47 37,47 Pyrazolo[1,5-a]pyrimidines as orally available inhibitors of cyclin-dependent kinase 2
0,00 0,00 Pyrazolopyrimidines as protein kinase inhibitors
0,00 0,00 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
0,00 0,00 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
37,47 37,47 Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors
Back
(c) Michal Bulant, 2011